Seaport Therapeutics presents new preclinical data on SPT-320 (Glyph Agomelatine) at the Society of Biological Psychiatry ...

Mind Medicine is developing MM120, a fast-acting, single-dose treatment for anxiety and depressive disorders. Read more on ...

In North America, particularly the United States, innovation in menopause care and a modern healthcare infrastructure provide a strong foundation for steady growth at a 3.00% CAGR through 2034. Canada ...

As scientific interest in psychedelic-assisted therapies continues to surge, MindScape Retreat, a licensed Ibogaine treatment facility located on the peaceful island of Cozumel, ...